Relationship between Gastric Inflammatory Response and Symptoms in Patients Infected withHelicobacter pylori (Q67937025)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1866592%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

title

Relationship between gastric inflammatory response and symptoms in patients infected with Helicobacter pylori (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1866592%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

Relationship between Gastric Inflammatory Response and Symptoms in Patients Infected withHelicobacter pylori (English)

1 reference

https://api.crossref.org/works/10.3109/00365529109093205

13 December 2022

1 reference

Helicobacter pylori infectious disease

1 reference

S. J. Czinn

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1866592

13 December 2022

T. A. Bertram

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1866592

13 December 2022

P. D. Murray

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1866592

13 December 2022

P. Yang

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1866592

13 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1866592

13 December 2022

publication date

1 January 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1866592%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

19 September 2019

http://www.tandfonline.com/doi/pdf/10.3109/00365529109093205

1 reference

https://api.crossref.org/works/10.3109/00365529109093205

Scandinavian Journal of Gastroenterology. Supplement

13 December 2022

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1866592%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

volume

181

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1866592%20AND%20SRC:MED&resulttype=core&format=json

19 September 2019

page(s)

33-37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1866592%20AND%20SRC:MED&resulttype=core&format=json

The presence of spirochetes in human gastric mucosa

19 September 2019

cites work

3

1 reference

https://api.crossref.org/works/10.3109/00365529109093205

Ultrastructure of cell migration throught the gastric epithelium and its relationship to bacteria

13 December 2022

4

1 reference

https://api.crossref.org/works/10.3109/00365529109093205

Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration

13 December 2022

8

1 reference

https://api.crossref.org/works/10.3109/00365529109093205

Clinical importance of Campylobacter pyloridis and associated serum IgG and IgA antibody responses in patients undergoing upper gastrointestinal endoscopy

13 December 2022

9

1 reference

https://api.crossref.org/works/10.3109/00365529109093205

Serum IgG antibody to the outer membrane proteins of Campylobacter pylori in children with gastroduodenal disease

13 December 2022

11

1 reference

https://api.crossref.org/works/10.3109/00365529109093205

Systemic and local antibody responses to gastric Campylobacter pyloridis in non-ulcer dyspepsia

13 December 2022

13

1 reference

https://api.crossref.org/works/10.3109/00365529109093205

Attempt to fulfil Koch's postulates for pyloric Campylobacter.

13 December 2022

14

1 reference

https://api.crossref.org/works/10.3109/00365529109093205

Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment

13 December 2022

16

1 reference

https://api.crossref.org/works/10.3109/00365529109093205

Susceptibility of clinical isolates of Campylobacter pyloridis to 11 antimicrobial agents

13 December 2022

17

1 reference

https://api.crossref.org/works/10.3109/00365529109093205

Effect of treatment on Campylobacter pylori in peptic disease: a randomised prospective trial

13 December 2022

18

1 reference

https://api.crossref.org/works/10.3109/00365529109093205

Effect of treatment on Campylobacter pylori in peptic disease: a randomised prospective trial

13 December 2022

19

1 reference

https://api.crossref.org/works/10.3109/00365529109093205

PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI

13 December 2022

20

1 reference

https://api.crossref.org/works/10.3109/00365529109093205

Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment

13 December 2022

22

1 reference

https://api.crossref.org/works/10.3109/00365529109093205

A method for the quantitation of small intestinal biopsy specimens

13 December 2022

23

1 reference

https://api.crossref.org/works/10.3109/00365529109093205

Non-ulcer dyspepsia: potential causes and pathophysiology

13 December 2022

25

1 reference

https://api.crossref.org/works/10.3109/00365529109093205

PROSPECTIVE DOUBLE-BLIND TRIAL OF DUODENAL ULCER RELAPSE AFTER ERADICATION OF CAMPYLOBACTER PYLORI

13 December 2022

29

1 reference

https://api.crossref.org/works/10.3109/00365529109093205

13 December 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1866592

13 December 2022

1 reference